- Home
- ATTO vs PWP Comparison
ATTO vs PWP Comparison
Compare ATTO & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATTO | PWP |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2026 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ATTO | PWP |
|---|---|---|
| Price | $17.70 | $14.33 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 264.4K | ★ 1.3M |
| Earning Date | N/A | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | N/A | ★ 138.52 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $28.86 |
| Revenue Next Year | N/A | $18.95 |
| P/E Ratio | ★ N/A | $183.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.15 | $12.52 |
| 52 Week High | $28.00 | $25.93 |
Technical Indicators
Market Signals| Indicator | ATTO | PWP |
|---|---|---|
| Relative Strength Index (RSI) | 34.80 | 44.98 |
| Support Level | $16.15 | $12.52 |
| Resistance Level | $24.89 | $17.51 |
| Average True Range (ATR) | 2.07 | 0.86 |
| MACD | -0.70 | 0.10 |
| Stochastic Oscillator | 9.50 | 47.20 |
Price Performance
Historical ComparisonAbout ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
About PWP Perella Weinberg Partners
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.